Bone marrow-derived progenitor cell dysfunction in ischemic heart disease and its relation to inflammation

被引：0
|
作者：
Nollet, Evelien [1 ]
Hoymans, V. Y. [1 ]
Rodrigus, I [2 ]
De Bock, D. [2 ]
Van Hoof, V. O. [3 ]
Dom, M. [4 ]
Vanassche, B. [5 ]
Vercruysse, H. [5 ]
Van Ackeren, K. [1 ]
Vrints, C. J. [1 ,6 ]
Van Craenenbroeck, E. M. [1 ,6 ]
机构：
[1] Univ Antwerp, Dept Translat Pathophysiol Res, Cardiovasc Dis, B-2020 Antwerp, Belgium
[2] Univ Antwerp Hosp, Dept Cardiac Surg, Antwerp, Belgium
[3] Univ Antwerp Hosp, Dept Clin Chem, Antwerp, Belgium
[4] Gen Hosp Sint Maarten, Dept Oral & Maxillofacial Surg, Antwerp, Belgium
[5] Gen Hosp AZ Monica, Dept Oral & Maxillofacial Surg, Antwerp, Belgium
[6] Univ Antwerp Hosp, Dept Cardiol, Antwerp, Belgium
来源：
ACTA CARDIOLOGICA | 2016年 / 71卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [1] Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease
    Nollet, Evelien
    Hoymans, Vicky Y.
    Rodrigus, Inez R.
    De Bock, Dina
    Dom, Marc
    Vanassche, Bruno
    Van Hoof, Viviane O. M.
    Cools, Nathalie
    Van Ackeren, Katrijn
    Wouters, Kristien
    Vermeulen, Katrien
    Vrints, Christiaan J.
    Van Craenenbroeck, Emeline M.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2016, 9 (04) : 266 - 278
  • [2] Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease
    Evelien Nollet
    Vicky Y. Hoymans
    Inez R. Rodrigus
    Dina De Bock
    Marc Dom
    Bruno Vanassche
    Viviane O. M. Van Hoof
    Nathalie Cools
    Katrijn Van Ackeren
    Kristien Wouters
    Katrien Vermeulen
    Christiaan J. Vrints
    Emeline M. Van Craenenbroeck
    Journal of Cardiovascular Translational Research, 2016, 9 : 266 - 278
  • [3] Bone marrow-derived stem cell therapy in ischemic heart disease
    Cho, Hyun-Jai
    Lee, Juyong
    Wecker, Andrea
    Yoon, Young-sup
    REGENERATIVE MEDICINE, 2006, 1 (03) : 337 - 345
  • [4] The extent of BM-derived progenitor cell dysfunction in ischemic heart disease and chronic heart failure in relation to inflammation
    Nonet, Evelien
    Hoymans, V. Y.
    Rodrigus, I
    De Bock, D.
    Van Hoof, V. O.
    Dom, M.
    Vanassche, B.
    Vercruysse, H.
    Van Ackeren, K.
    Wouters, Kristien
    Vrints, C. J.
    Van Craenenbroeck, E. M.
    ACTA CARDIOLOGICA, 2016, 71 (01) : 90 - 90
  • [5] Mixed Results for Bone Marrow-Derived Cell Therapy for Ischemic Heart Disease
    Marban, Eduardo
    Malliaras, Konstantinos
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (22): : 2405 - 2406
  • [6] Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure
    Wen, Yanting
    Chen, Bing
    Wang, Chen
    Ma, Xiaodong
    Gao, Qian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (12) : 1563 - 1573
  • [7] Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease
    Reffelmann, Thorsten
    Kloner, Robert A.
    REGENERATIVE MEDICINE, 2009, 4 (05) : 709 - 719
  • [8] Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease
    Nollet, Evelien
    Hoymans, Vicky Y.
    Rodrigus, Inez R.
    De Bock, Dina
    Dom, Marc
    Van Hoof, Viviane O. M.
    Vrints, Christiaan J.
    Van Craenenbroeck, Emeline M.
    ATHEROSCLEROSIS, 2017, 260 : 138 - 146
  • [9] Bone marrow-derived progenitor cells and outcome in patients with ischemic stroke
    Cesari, F.
    Gori, A. M.
    Marcucci, R.
    Nencini, P.
    Pracucci, G.
    Palumbo, V.
    Inzitari, D.
    Gensini, G. F.
    Abbate, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 980 - 980
  • [10] Aldosterone impairs bone marrow-derived progenitor cell formation
    Marumo, Takeshi
    Uchimura, Hideki
    Hayashi, Matsuhiko
    Hishikawa, Keiichi
    Fujita, Toshiro
    HYPERTENSION, 2006, 48 (03) : 490 - 496
12345